Akebia Ther (AKBA) — Cash Flow-to-Debt Ratio
Akebia Ther (AKBA) has a Cash Flow-to-Debt Ratio of 0.09x as of December 2025, meaning its operating cash flow of $31.13 Million could theoretically repay 0% of its total liabilities ($343.95 Million) in one year. See Akebia Ther (AKBA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Akebia Ther Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Akebia Ther across 14 annual periods. Also explore Akebia Ther (AKBA) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Akebia Ther (2012–2025)
Year-by-year debt coverage analysis for Akebia Ther. For market capitalisation and broader financial context, see Akebia Ther stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | $67.99 Million | $343.95 Million | ▲ +231.2% |
| 2024 | -0.15x | $-40.66 Million | $269.86 Million | ▼ -75.4% |
| 2023 | -0.09x | $-23.38 Million | $272.29 Million | ▲ +58.8% |
| 2022 | -0.21x | $-73.15 Million | $350.82 Million | ▲ +62.5% |
| 2021 | -0.56x | $-252.97 Million | $455.34 Million | ▼ -99.6% |
| 2020 | -0.28x | $-110.39 Million | $396.52 Million | ▲ +59.3% |
| 2019 | -0.68x | $-257.44 Million | $376.44 Million | ▼ -153.0% |
| 2018 | -0.27x | $-97.49 Million | $360.61 Million | ▼ -17.9% |
| 2017 | -0.23x | $-56.16 Million | $244.92 Million | ▼ -191.9% |
| 2016 | 0.25x | $57.91 Million | $232.10 Million | ▲ +105.7% |
| 2015 | -4.39x | $-52.41 Million | $11.94 Million | ▼ -10.5% |
| 2014 | -3.97x | $-27.48 Million | $6.92 Million | ▼ -37.1% |
| 2013 | -2.90x | $-11.33 Million | $3.91 Million | ▼ -97.9% |
| 2012 | -1.46x | $-7.21 Million | $4.92 Million | — |